STOCKHOLM--(BUSINESS WIRE)--SciBase, a Swedish medtech company that develops and markets a new technology for early detection of malignant melanoma, together with its partner KTH Royal Institute of Technology, have been granted 3.9 MSEK from Vinnova’s ‘Smarter Electronic Systems’ program fund. The project is for the development of a minimized and modular next generation of SciBase’s product Nevisense. The project’s objective is to minimize the size of measurement electronics, which is essential
For more information, please visit
http://www.businesswire.com/news/home/20[...].9-MSEK-Development-Generation